and breast cancer)over-expressing Fascin1, Cancer(colon cancer stage II-III, rectal cancer
Conditions
Brief summary
Changes in the invading front associated with the epithelial-mesenchymal transition quantified as measurement of tumor budding, cytoplasmic pseudofragments, pattern of tumor invasion, and characteristics of the immune infiltrate (intra- and peritumoral lymphocytes, characterization of Crohn-like response macrophages).
Detailed description
Evaluation of plasma quantification of tumor DNA copies and the expression of serum and tissue fascina1 in the surgical resection piece.
Interventions
DRUGSucrose c.s. and lactose c.s.
DRUGTOFRANIL 50 mg comprimidos recubiertos
Sponsors
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the invading front associated with the epithelial-mesenchymal transition quantified as measurement of tumor budding, cytoplasmic pseudofragments, pattern of tumor invasion, and characteristics of the immune infiltrate (intra- and peritumoral lymphocytes, characterization of Crohn-like response macrophages). | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of plasma quantification of tumor DNA copies and the expression of serum and tissue fascina1 in the surgical resection piece. | — |
Countries
Spain
Outcome results
None listed